Supplementary Table 1 - Gene Expression from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance

Supplementary Table 1 - Gene Expression from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance

<p>Gene Expression-RNAseq. Summary gene expression data of the individual tumors included in Fig. 5a-c.</p>

保存先:

書誌詳細
第一著者:	Renzo Perales-Linares (17314863) (author)
その他の著者:	Nektaria Maria Leli (17314866) (author), Hesham Mohei (17314869) (author), Silvia Beghi (17314872) (author), Osvaldo D. Rivera (17314875) (author), Nektarios Kostopoulos (17314878) (author), Andrea Giglio (17314881) (author), Subin S. George (17314884) (author), Mireia Uribe-Herranz (17314887) (author), Francesca Costabile (17314890) (author), Stefano Pierini (17314893) (author), Sergei Pustylnikov (17314896) (author), Giorgos Skoufos (14865857) (author), Yoseph Barash (15130157) (author), Artemis G. Hatzigeorgiou (17314899) (author), Constantinos Koumenis (14865905) (author), Amit Maity (17314902) (author), Michael T. Lotze (14937723) (author), Andrea Facciabene (17314905) (author)
出版事項:	2025
主題:	Cancer Tumor Biology Immuno-oncology Immunology Tumor resistance to immune response Immunotherapy Combination immunotherapy Progression, Invasion & Metastasis Tumor progression
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Supp. Figure 1 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 2 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 3 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 4 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 5 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Supp. Figure 6 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
著者:: Renzo Perales-Linares (17314863)
出版事項: (2025)

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
著者:: Xiaodong Shu (16721586)
出版事項: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
著者:: Xiaodong Shu (16721586)
出版事項: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
著者:: Xiaodong Shu (16721586)
出版事項: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
著者:: Xiaodong Shu (16721586)
出版事項: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
著者:: Xiaodong Shu (16721586)
出版事項: (2025)

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
著者:: Xiaodong Shu (16721586)
出版事項: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
著者:: Xiaodong Shu (16721586)
出版事項: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
著者:: Xiaodong Shu (16721586)
出版事項: (2025)

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
著者:: Francisco Hermida-Prado (14958909)
出版事項: (2025)

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
著者:: Renumathy Dhanasekaran (14962092)
出版事項: (2025)

Supplementary Table1 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
著者:: Yidan Ren (14845140)
出版事項: (2025)

Supplementary Table2 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
著者:: Yidan Ren (14845140)
出版事項: (2025)

Supplementary Table3 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
著者:: Yidan Ren (14845140)
出版事項: (2025)

Supplementary Table 7_Genes identified by differential expression analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
著者:: Niccolò Roda (16437288)
出版事項: (2025)

Figure S.1 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
著者:: Xufeng Lu (14960724)
出版事項: (2025)

Figure S.2 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
著者:: Xufeng Lu (14960724)
出版事項: (2025)

Figure S.3 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
著者:: Xufeng Lu (14960724)
出版事項: (2025)

Figure S.4 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
著者:: Xufeng Lu (14960724)
出版事項: (2025)

Figure S.5 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
著者:: Xufeng Lu (14960724)
出版事項: (2025)

Figure S.6 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
著者:: Xufeng Lu (14960724)
出版事項: (2025)

Figure S.7 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
著者:: Xufeng Lu (14960724)
出版事項: (2025)

Figure S.8 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
著者:: Xufeng Lu (14960724)
出版事項: (2025)

Supplementary Table 6_Gene modules analysis_GO and curated pathways associated to gene modules from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
著者:: Niccolò Roda (16437288)
出版事項: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
著者:: Isha Mondal (16721699)
出版事項: (2025)

Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
著者:: Carlotta Antoniotti (15352506)
出版事項: (2025)

Supplementary Figure S2 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
著者:: Carlotta Antoniotti (15352506)
出版事項: (2025)

Supplementary Figure S3 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
著者:: Carlotta Antoniotti (15352506)
出版事項: (2025)

Supplementary Table 9_Pro metastatic pathways identified by differential expression singlePT setting from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
著者:: Niccolò Roda (16437288)
出版事項: (2025)

Figure 1 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
著者:: Massimiliano Mellone (14959419)
出版事項: (2025)

Figure 2 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
著者:: Massimiliano Mellone (14959419)
出版事項: (2025)

Figure 3 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
著者:: Massimiliano Mellone (14959419)
出版事項: (2025)

Figure 4 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
著者:: Massimiliano Mellone (14959419)
出版事項: (2025)

Figure 5 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
著者:: Massimiliano Mellone (14959419)
出版事項: (2025)

Figure 6 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
著者:: Massimiliano Mellone (14959419)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_iuao5v4fd7rcbsc2g32mtrgq5f